Search

everythinglearnresearchcommunity

for

Search:↓

Androgens play a key role in hair growth and disorders like baldness and excessive hairiness.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Androgens slow hair growth by altering Wnt signaling in balding cells.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Androgens increase a growth factor in hair cells by creating reactive oxygen species, and antioxidants might help treat hair loss.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.